TrialCancer immunology, immunotherapy : CII2010

Foxp3(+) cell infiltration and granzyme B(+)/Foxp3(+) cell ratio are associated with outcome in neoadjuvant chemotherapy-treated ovarian carcinoma.

Martin Pölcher et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.